|
|
||||||||
EDUCATION EXHIBIT |
1 From the Department of Diagnostic Radiology, Konyang University Hospital, 685 Gasuwon-dong, Seo-gu, Daejeon City 302718, South Korea (J.H.K.); and the Department of Pediatrics, Genetic Clinics, Ajou University Hospital, Suwon, South Korea (H.J.K.). Presented as an education exhibit at the 2003 RSNA Scientific Assembly. Received May 21, 2004; revision requested September 10 and received January 3, 2005; accepted January 5. All authors have no financial relationships to disclose. Address correspondence to J.H.K. (e-mail: radol{at}unitel.co.kr).
X-linked adrenoleukodystrophy (ALD) is a rare metabolic disorder caused by peroxisomal enzyme failure. Several phenotypes can be distinguished on the basis of clinical onset and manifestations. Childhood cerebral X-linked ALD is the most severe phenotype, resulting in rapid neurologic deterioration and early death. Patients with this disease may be hospitalized with far-advanced central nervous system (CNS) lesions or may complain of symptoms similar to those of certain psychiatric disorders, possibly leading to a wrong diagnosis. Although the general prognosis for patients with childhood cerebral X-linked ALD is still poor, new treatment modalities have been introduced, some of which are helpful in relieving clinical symptoms and prolonging life. With the introduction of these new therapies and increased clinical detection of childhood cerebral X-linked ALD, brain magnetic resonance (MR) imaging has become an essential tool for initial and follow-up evaluation. MR imaging allows early detection of CNS lesions and helps differentiate childhood cerebral X-linked ALD from other disorders. The characteristic MR imaging features of childhood cerebral X-linked ALD have been well documented, although most radiologists have limited experience with serial follow-up MR imaging in this context. Familiarity with the clinical-pathologic manifestations and progressive MR imaging features of childhood cerebral X-linked ALD will be helpful in evaluating affected patients.
© RSNA, 2005
Abbreviations: ALD = adrenoleukodystrophy, AMN = adrenomyeloneuropathy, CNS = central nervous system, FLAIR = fluid-attenuated inversion recovery, VLCFA = very long chain fatty acid
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOGRAPHICS | RADIOLOGY | RSNA JOURNALS ONLINE |